Centogene has appointed Richard Stoffelen as its new CFO. Stoffelen previously served as head of internal audits at Holcim. From 1991 to 2013, he was active in different audit and management positions at KPMG.
OmniSeq has appointed Mark Gardner as its CEO and as a member of its board of directors. Gardner is currently vice president and general manager for Thermo Fisher Scientific's next generation clinical sequencing business. He will transition to his new role at OmniSeq in April. Prior to his work at Thermo Fisher, Gardner held senior management positions at McKinsey, GE Medical Systems, Invitrogen, and Life Technologies.
Timothy Burcham and Steven Arnold
Lasergen has appointed Timothy Burcham as its CTO. He will help develop the firm's sequencing platform. Burcham has been a member of the firm's scientific advisory board since 2015, and previously spent time developing and launching sequencing systems at Applied Biosystems. The firm also plans to rearrange its board to accommodate three seats from Agilent and will add Steven Arnold, a management consultant who also serves on the board at Houston Methodist Research Institute and Texas Children's Hospital Cancer Center.
For more recent items on executive appointments and promotions in the omics and molecular diagnostics industries, please see the People in the News page on our website.